Ventajas y desventajas del inhibidor del cotransportador de sodio y glucosa en Diabetes Mellitus 2

Abstract

Background. Sodium-glucose cotransporter type 2 inhibitors represent a recent alternative in the management of type 2 diabetes mellitus. In the last decade, several programs and large-scale studies have been carried out to study their benefits, however, they were also identified. even serious adverse effects that should be checked before applying them in clinical practice. Objectives. To update the advantages and disadvantages of the use of sodium-glucose cotransporter type 2 inhibitors in patients with type 2 diabetes mellitus. Methodology. Statistical-based systematic bibliographic review, study review, meta-analysis of randomized controlled trials, case reports published in the last 5 years in portals such as Pubmed, The new journal of medicine, Springer and Medline.